cytarabine has been researched along with eicosapentaenoic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Muto, T; Nagawa, H; Tsai, WS | 1 |
Atkinson, TG; Barker, HJ; Meckling-Gill, KA | 1 |
Bay, JO; Béné, MC; Bertrand, P; Bonmati, C; Carré, M; Darrouzain, F; Gallego-Hernanz, MP; Gyan, E; Hérault, O; Hunault, M; Lioure, B; Peterlin, P; Picou, F; Pigneux, A; Récher, C; Ternant, D; Vallet, N | 1 |
4 other study(ies) available for cytarabine and eicosapentaenoic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Differential effects of polyunsaturated fatty acids on chemosensitivity of NIH3T3 cells and its transformants.
Topics: 3T3 Cells; Animals; Antibiotics, Antineoplastic; Cell Line, Transformed; Cytarabine; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Mice; Mitomycin | 1997 |
Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats.
Topics: Animals; Animals, Suckling; Antimetabolites, Antineoplastic; Body Weight; Bone Marrow; Bone Marrow Cells; Cholesterol; Cytarabine; Diarrhea; Diet; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Hair; Heart; Hematopoietic Stem Cells; Immunosuppressive Agents; Liver; Male; Muscle, Skeletal; Myocardium; Phospholipids; Rats; Rats, Inbred F344; Tissue Distribution; Triglycerides | 1997 |
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Docosahexaenoic Acids; Eicosapentaenoic Acid; Emulsions; Feasibility Studies; Fish Oils; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; NF-E2-Related Factor 2 | 2022 |